Convalescent Plasma
/ Hospital San Jose Tec De Monterrey
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
February 10, 2021
Safety in Convalescent Plasma Transfusion to COVID-19
(clinicaltrials.gov)
- P1; N=12; Terminated; Sponsor: Hospital San Jose Tec de Monterrey; N=20 ➔ 12; Trial completion date: Apr 2021 ➔ Aug 2020; Recruiting ➔ Terminated; Trial primary completion date: Dec 2020 ➔ Aug 2020; Other clinical trails probed that the use of convalescent plasma for patients with COVID-19 is safe .
Clinical • Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
August 26, 2020
EPCOvid-1: Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19
(clinicaltrials.gov)
- P2b; N=410; Recruiting; Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Not yet recruiting ➔ Recruiting; N=250 ➔ 410
Enrollment change • Enrollment open • Infectious Disease • Novel Coronavirus Disease
May 14, 2020
EPCOvid-1: Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19
(clinicaltrials.gov)
- P2b; N=250; Not yet recruiting; Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Clinical • New P2b trial • Infectious Disease • Novel Coronavirus Disease
May 08, 2020
Safety in Convalescent Plasma Transfusion to COVID-19
(clinicaltrials.gov)
- P1; N=20; Recruiting; Sponsor: Hospital San Jose Tec de Monterrey; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease
April 03, 2020
Safety in Convalescent Plasma Transfusion to COVID-19
(clinicaltrials.gov)
- P1; N=20; Not yet recruiting; Sponsor: Hospital San Jose Tec de Monterrey
Clinical • New P1 trial
1 to 5
Of
5
Go to page
1